This medicine contains the cyamemazine in the form of scored tablets 25 mg box of 30 and 100 mg scored tablets in a box of 25 and 40 mg / ml oral solution bottle of 30 ml syringe metering or 1200 drops.
The Tercian are also in injectable solution 50 mg per 5 ml in a box of 5 ampoules of 5 ml.

The cyamemazine is a neuroleptic belonging to the chemical family of phenothiazines with outside other properties, the capacity to have an intense atropinique effect not involved in the drug activity may explain certain contraindications.
This medication is used to treat mental disorders, depression of short duration in combination with an antidepressant and significant anxiety.

Contraindications
Closed angle glaucoma risk
Risk of blockage of urine (adenoma of prostate)
Agranulocytosis
Dopaminergic drug
Association with drugs containing the sultopride and an antidepressant drugs or drug with atropine
Some gastric dressings.
Pregnancy and breastfeeding

Adverse effects
Drowsiness
Dry mouth
Constipation
Disorders of accommodation
Retention of urine
Orthostatic hypotension
Involuntary movement
Tics
Muscle stiffness
Increase in prolactin secretion
Diabetes
Hyperglycemia
Allergic skin reaction
Photosensitization
Cardiac arrhythmia (torsades de pointes)
Neuroleptic Malignant Syndrome
Agranulocytosis

Comments
The cyamemazine allows in theory control of nervous disorders. The undesired case faces a severe relapse. This drug is likely to cause a decrease in the number of white blood cells in the blood which must be monitored by analyses in case of occurrence of angina for example or ulcerations of the mouth among others.
In the case of muscle stiffness it is necessary to stop processing after medical advice. Between in Neuroleptic Malignant syndrome.
This drug, as all of the atropiniques, is likely to lead to an acute glaucoma in people with a predisposition that is a red eye which is hard and that combines pain or vision blurred. In this case the patient requires a consultation with an ophthalmologist urgently.
In patients with Parkinson’s disease this drug, without exception, must not be used.
It is same in patients at risk of torsades de pointes (the advice of a cardiologist).
The taking of alcohol and tobacco is discouraged during this treatment.
The cyamemazine is likely to cause, among drivers, sometimes intense sleepiness. The alcohol intake increases this risk.